Vyome Holdings HIND
NASDAQ HIND
$2.25 -0.03 (-1.32%)
As of: Aug 21, 2026 · 3:38 PM EDT

Vyome Holdings (HIND) Gross Profit (2015 - 2026)

Vyome Holdings (HIND) posted quarterly Gross Profit of $16645.0 for Q1 2026, down 89.22% year-over-year from $154419.0 in Q1 2025, and down 24.57% quarter-over-quarter from $22066.0 in Q4 2025.

Vyome Holdings (HIND) Gross Profit (2015 - 2026) Analysis & Trends

Vyome Holdings' Gross Profit history runs 12 years deep, the most recent figure standing at $16645.0 for Q1 2026.

  • In Q1 2026, Gross Profit fell 89.22% year-over-year to $16645.0; the TTM figure through Mar 2026 stood at $655761.0 (down 52.76% YoY), while the FY2025 annual figure was $218771.0, up 12.21% from the prior year.
  • Gross Profit for Q1 2026 stood at $16645.0, down from $22066.0 in the prior quarter.
  • The five-year high for Gross Profit was $2.1 million in Q3 2022, with the low at $16645.0 in Q1 2026.
  • The 5-year median for Gross Profit is $1.2 million (2024), against an average of $915236.8.
  • The sharpest annual moves came in 2023 and 2024: Gross Profit increased 15.13% in 2023, then slumped 97.12% in 2024.
  • Vyome Holdings' Gross Profit stood at $1.6 million in 2022, then climbed by 15.12% to $1.8 million in 2023, then tumbled by 96.59% to $62761.0 in 2024, then tumbled by 64.84% to $22066.0 in 2025, then slipped by 24.57% to $16645.0 in 2026.
  • Business Quant data shows HIND's Gross Profit at $16645.0 in Q1 2026, $22066.0 in Q4 2025, and $18050.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Vyome Holdings 16.07 Mn 8.18 Mn 11,658.00

Historic Data

Download Data
DateValue
Jun 30, 2026 11,658.00
Jun 30, 2026 11,658.00
Mar 31, 2026 16,645.00
Mar 31, 2026 16,645.00
Dec 31, 2025 22,066.00
Dec 31, 2025 22,066.00
Sep 30, 2025 18,050.00
Sep 30, 2025 18,050.00
Jun 30, 2025 599,000.00
Jun 30, 2025 599,000.00
Mar 31, 2025 154,419.00
Mar 31, 2025 154,419.00
Dec 31, 2024 62,761.00
Dec 31, 2024 62,761.00
Sep 30, 2024 37,085.00
Sep 30, 2024 37,085.00
Jun 30, 2024 1.13 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.17 Mn
Mar 31, 2024 1.17 Mn